Patient-oriented and far-sighted treatment

A personalized treatment strategy has become an important basic principle in diabetes therapy. In addition to taking into account inter-individual differences in patient characteristics, certain clusters in relation to the risks of microvascular and macrovascular complications should also be kept in mind when selecting therapy. With the use of the modern substance classes of SGLT-2-i and GLP-1-RA, different risk constellations can be taken into account.